Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes
about
Current Advances in Virus-Like Particles as a Vaccination Approach against HIV InfectionDendritic Cell-Based Immunotherapies to Fight HIV: How Far from a Success Story? A Systematic Review and Meta-AnalysisA novel liposome-based adjuvant CAF01 for induction of CD8(+) cytotoxic T-lymphocytes (CTL) to HIV-1 minimal CTL peptides in HLA-A*0201 transgenic mice.Shaping successful and unsuccessful CD8 T cell responses following infection.Responses against a subdominant CD8+ T cell epitope protect against immunopathology caused by a dominant epitope.DNA vaccines encoding altered peptide ligands for SSX2 enhance epitope-specific CD8+ T-cell immune responsesAdvances in the study of HLA-restricted epitope vaccines.Vaccination with lipid core peptides fails to induce epitope-specific T cell responses but confers non-specific protective immunity in a malaria modelDevelopment of skewed functionality of HIV-1-specific cytotoxic CD8(+) T cells from primary to early chronic phase of HIV infection.HIV control is mediated in part by CD8+ T-cell targeting of specific epitopes.A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication.Broadening of the T-cell repertoire to HIV-1 Gag p24 by vaccination of HLA-A2/DR transgenic mice with overlapping peptides in the CAF05 adjuvantA therapeutic dendritic cell-based vaccine for HIV-1 infection.The case for a rational genome-based vaccine against malaria.HIV-Specific CD8(+) T Lymphocytes in Blood of Long-Term HIV-Infected Hemophilia Patients.Definition of the viral targets of protective HIV-1-specific T cell responsesNon-immunogenicity of overlapping gag peptides pulsed on autologous cells after vaccination of HIV infected individuals.Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial.Therapeutic vaccines against HIV infection.Dendritic cell based vaccines for HIV infection: the way ahead.Future considerations for dendritic cell immunotherapy against chronic viral infections.New challenges in therapeutic vaccines against HIV infection.PD-1 or PD-L1 Blockade Restores Antitumor Efficacy Following SSX2 Epitope-Modified DNA Vaccine ImmunizationInterleukin-12p70 expression by dendritic cells of HIV-1-infected patients fails to stimulate gag-specific immune responses.Immune hierarchy among HIV-1 CD8+ T cell epitopes delivered by dendritic cells depends on MHC-I binding irrespective of mode of loading and immunization in HLA-A*0201 mice.Mosaic HIV-1 Gag antigens can be processed and presented to human HIV-specific CD8+ T cells.An immunoregulatory role of dendritic cell-derived exosomes versus HIV-1 infection: take it easy but be warnedSequence analysis of HIV-1 isolates from Guinea-Bissau: selection of vaccine epitopes relevant in both West African and European countries.Arcelis AGS-004 dendritic cell-based immunotherapy for HIV infection.
P2860
Q26775082-A22CFCA5-37D4-4C18-9CFF-C56EF6415E4FQ28070121-01232B32-39FA-4C93-B2B4-9E3A37D5ECE2Q33504189-47F73656-C33F-4307-8643-A445CA998FD7Q33771963-89A6EDC1-C2E4-489B-86FD-333B6BC9CCA8Q34089255-235EC828-7956-4FAE-B2D9-66DFF1BB714CQ34127323-98E20239-9511-4CD8-ACE6-53553FB5D55BQ34170130-77B5E4AD-26A7-4033-A9A4-FCA8D24D3B8EQ34398787-1B9BDF35-4E33-4B70-9AA0-6421A8723033Q34427822-F54C8960-3F04-44D7-B3B2-31A0DB1659B2Q34594538-FBD7A20F-CC61-4F57-842D-827CBCBF5682Q34646987-9D20EF1E-DD8C-4D06-A736-9D64070A256AQ34730713-476AAA67-098E-482A-96F6-45BD02B9C254Q34764392-4F79401B-9376-458B-A873-490DAE37D3F8Q34999392-EA6BF0E1-5DF4-474C-8AC7-1D2087E20A75Q35079104-E9099D01-6944-49C7-A98D-48926A9548E1Q35800157-2C6C2362-F643-4B08-9E90-1B713DBD00DFQ37215858-CD7493E5-905B-4B18-9F2A-435B4A4EE7B0Q37381097-B5BB4D52-9C77-4822-A60D-192A40C66DC3Q38013505-E81CB7A1-80B1-443A-873C-4B755571A357Q38126373-71C55027-6BB1-446D-BCA3-E954401BAC0AQ38204769-DD9553C1-32BD-422E-B5DD-BEE830107D41Q38692205-792C420A-F40B-4CF6-98BC-B36B58535B90Q38867768-1F04A81C-FC36-4FC4-A371-3C9EE3D60A26Q39550595-C5392539-5667-4513-8FB7-7675B03A4A6CQ41958079-4B4E27F4-637A-4108-9C9A-A2E38782F8BDQ42269255-DF199092-C194-4FD6-A86D-CB91A5EC424AQ42359045-48A0850B-582F-4A3B-948D-4D88F014C722Q44216622-9822947A-98F2-4263-9C96-F7F619B09D98Q44606374-F2508295-4989-4646-A97F-6F204343AE5E
P2860
Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes
description
article
@en
im Juli 2009 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2009
@uk
name
Induction of novel CD8+ T-cell ...... ytotoxic T-lymphocyte epitopes
@en
Induction of novel CD8+ T-cell ...... ytotoxic T-lymphocyte epitopes
@nl
type
label
Induction of novel CD8+ T-cell ...... ytotoxic T-lymphocyte epitopes
@en
Induction of novel CD8+ T-cell ...... ytotoxic T-lymphocyte epitopes
@nl
prefLabel
Induction of novel CD8+ T-cell ...... ytotoxic T-lymphocyte epitopes
@en
Induction of novel CD8+ T-cell ...... ytotoxic T-lymphocyte epitopes
@nl
P2093
P50
P1433
P1476
Induction of novel CD8+ T-cell ...... ytotoxic T-lymphocyte epitopes
@en
P2093
Betina S Andresen
Gitte Kronborg
Ingrid Karlsson
Jan Gerstoft
Mette Thorn
P304
P356
10.1097/QAD.0B013E32832D9B00
P407
P50
P577
2009-07-01T00:00:00Z